Lang v. Rogue Valley Medical Center – Unilateral DNR and Withholding Lawsuit
The Oregon Supreme Court has just issued a judgment allowing a medical futility lawsuit to proceed to trial.
In 2001, Ruth Miller was diagnosed with multiple myeloma. Seven years later, in 2008, she executed an advance directive, naming Phillip Lang as her health care representative.
On August 1, 2008, Miller was admitted into Rogue Valley Medical Center, where she died that night. Lang brought a lawsuit against the Medical Center and Miller's oncologist, asserting claims for wrongful death, negligence, medical malpractice, and abuse of a vulnerableperson.
Lang alleges that Miller was not capable of making medical d...
Source: blog.bioethics.net - July 1, 2017 Category: Medical Ethics Authors: Thaddeus Mason Pope, JD, PhD Tags: Health Care syndicated Source Type: blogs
Engineering Immune Organoids : An Interview with Prof. Ankur Singh from Cornell University
Organ-on-a-chip technologies are redefining the way in which in vitro models help understand and recapitulate the in vivo environment. The immune system is particularly difficult to model in an in vitro environment because of the complexity of biological, mechanical, and chemical cues that modulate the immune cells. Prof. Ankur Singh, an assistant professor in the Sibley School of Mechanical and Aerospace Engineering at Cornell University, has led the development of organ-on-a-chip models to mimic the complex immune environment.
B cell lymphomas grow in organoids as clusters, similar to those in patients. The green fluores...
Source: Medgadget - June 30, 2017 Category: Medical Devices Authors: Rukmani Sridharan Tags: Exclusive Genetics Medicine Source Type: blogs
My current protocol
I have been getting quite a number of requests from blog readers wanting to know more or less the same things: how much curcumin I take, how I take it (with a fat, with cocoa, etc.)…and so on and so forth…
Instead of replying to each and every one of you, which would take heaps of time, I decided to write a quick post today about this issue.
Dosage: Every day I take 8 grams of C3 Complex curcumin = the curcumin that has been used in the MM, SMM, and MGUS clinical trials.
As for brands, I prefer Doctor’s Best, simply because of its easy-to-take one-gram tablets, which you can sometimes find at a relativel...
Source: Margaret's Corner - June 29, 2017 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll curcumin protocol Source Type: blogs
Excellent videos offered by Myeloma UK
I just finished watching one of the, as my post’s title suggests, one of the excellent videos offered by Myeloma UK. This one was called “The effect of myeloma on the bone marrow.” Here’s the link: goo.gl/zfCU5n,
You will find many more animations on the Myeloma UK website, explaining, in easy-to-understand language, all sorts of things, from the origin of the myeloma cell to the genetic causes of myeloma…Plus it has interviews with patients and also doctors on all sorts of topics, including fatigue caused by myeloma, travel issues, issues for younger patients…And much, much more.
Hig...
Source: Margaret's Corner - June 19, 2017 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll Myeloma UK Source Type: blogs
A Johns Hopkins researcher discovers a way that may slow down or even eliminate cancer metastasis
I just finished reading a fascinating article about a very promising new discovery, which may be able to actually eliminate metastasis, that is, the spread of cancer from its primary site to new areas of the body.
And I quote: “Typically, cancer research and treatment has focused on shrinking the primary tumor through chemotherapy or other methods. But, the team said, by attacking the deadly process of metastasis, more patients could survive.” Aha. Interesting, very interesting…
The article is really easy to read, so, without further ado, here’s the link: goo.gl/ibM91B
By the way, the article men...
Source: Margaret's Corner - June 16, 2017 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll Source Type: blogs
Persuing ASCO 2017 - AKA Time for Lorazepam
Photo from ASCO Mediakit. © ASCO/Danny Morton 2017TheAnnual Meeting of the American Society of Clinical Oncology was last week. It ’s been my observation over the years that much of the best palliative-oncology and supportive-oncology research is presented at ASCO each year, before it’s actually published (if it ever gets published). So I always dig through the palliative/EOL/supportive/psychooncology abstracts each year to see what ' s happening. Below is a gently annotated list of the abstracts that caught my eye the most, for your perusal and edification. Undoubtedly, these are my idiosyncratic choices, ...
Source: Pallimed: A Hospice and Palliative Medicine Blog - June 8, 2017 Category: Palliative Care Tags: ASCO cancer oncology pallonc research research issues rosielle WaPo Source Type: blogs
Cures
In the past few days I have learned of treatment breakthroughs for Multiple Myeloma and for Multiple Sclerosis - I have two friends which this will benefit. Both of them are very happy to learn about the progress.TheMultiple Myeloma (MM) news is that they have now found a treatment using immunotherapy which seems to put almost everyone into remission. MM is not curable but if patients can be put into long term remission with this new treatment, it looks like it is a step towards a cure. This news was announced at the ASCO conference last weekend." ASCO Perspective“While it’s still early, these data are a strong sign th...
Source: Caroline's Breast Cancer Blog - June 8, 2017 Category: Cancer & Oncology Tags: cancer cure cancer research medical research Source Type: blogs
Chimeric Antigen Receptor Therapies Continue to Do Well Against Blood Cancers
Chimeric antigen receptor approaches to cancer treatment involve taking a patient's T cells and equipping them with a new receptor that allows the immune cells to target specific characteristics of cancer cells. Despite the usual complications and challenges that tend to occur in the development of immunotherapies, involving potentially dangerous disruption of the immune system, this type of therapy has proven to be highly effective against blood cancers. It remains to be deployed against solid cancers, although researchers are well on their way towards reaching that goal, but there is every reason to expect it to be just ...
Source: Fight Aging! - June 6, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
My blog … mentioned in a BBC radio programme!
Even though my blog reader D. had told me some time ago that my blog might be mentioned in the BBC radio station that had interviewed her for the programme they were doing on turmeric, I was happy about that, of course, but I hadn’t really gotten too carried away…until today, when I found and actually listened to the programme, which is available online, right here: goo.gl/Gmda8N
Dieneke’s case study is mentioned toward the end of the programme, so please be patient. It’s a very interesting programme, anyway. With a nice turmeric-based recipe or two, which never hurts!
I have to admit that I go...
Source: Margaret's Corner - May 30, 2017 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll BBC Radio 4 curcumin Food Programme myeloma Sheila Dillon turmeric Source Type: blogs
“ Long-term follow-up of curcumin treated MGUS/SMM patients – an updated single centre experience ”
In an email I received yesterday, Dr. Terry Golombick notified me that her team’s most recent article has been published in the Journal of Hematology and Medical Oncology. It is available for free online…just click here: goo.gl/cEP93h
Ahhhh. Wonderful…absolutely wonderful.
Wonderful, because finally…FINALLY (!!!)…we have a long-term look at a GROUP of MGUS and SMM patients taking curcumin. These are those who participated in the Australian MGUS/SMM study and who “continued to take curcumin over a number of years, of their own volition, even though the studies in which they were par...
Source: Margaret's Corner - May 12, 2017 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll blood cancers curcumin Dr. Terry Golombick MGUS myeloma SMM Source Type: blogs
